Article Details

Oncorena Receives Approval of First in Patient Trial with Orellanine as a Potential Breakthrough ...

Retrieved on: 2021-03-01 07:07:30

Tags for this article:

Click the tags to see associated articles and topics

Oncorena Receives Approval of First in Patient Trial with Orellanine as a Potential Breakthrough .... View article details on hiswai:

Excerpt

... biotechnology company AQILION AB and HealthCap, a major European venture capital fund investing globally in life sciences.For more information ...

Article found on: www.prnewswire.co.uk

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up